Hypertonic Modulation of Inflammation Following Injury
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This project seeks to determine the effect of prehospital resuscitation with hypertonic saline vs. conventional crystalloids on the inflammatory response after injury. The leading cause of late mortality following injury is multiple organ dysfunction syndrome (MODS), which results from a dysfunctional inflammatory response after injury. Previous studies suggest that hypertonic saline may be beneficial by modulating this initial response and decreasing subsequent organ injury. This project takes advantage of a unique opportunity, afforded by an NIH-funded multi-center clinical trial of hypertonic resuscitation (conducted by the Resuscitation Outcomes Consortium), to obtain blood samples from patients enrolled in this trial to analyze inflammatory responses early after hypertonic vs. conventional resuscitation.
The proposed study will be carried out in experiments grouped in three Specific Aims: Aim 1 provides a thorough investigation of the immunomodulatory response following hypertonic resuscitation with regard to neutrophil, monocyte, and T cell responses at serial time points after injury and resuscitation. Aim 2 comprises experiments to investigate the mechanisms by which hypertonicity may alter inflammatory cell signaling. Aim 3 seeks to correlate the laboratory findings with clinical endpoints reflective of immune dysfunction including inflammation, organ failure, nosocomial infection, and sepsis.
The investigators hypothesize that hypertonic resuscitation will be associated with modulation of the excessive inflammatory response seen after injury and thus will result in reduced rates of inflammatory organ injury.
| Condition |
|---|
|
Hemorrhagic Shock Traumatic Brain Injury |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Hypertonic Modulation of Inflammation Following Injury |
plasma
| Enrollment: | 119 |
| Study Start Date: | November 2007 |
| Study Completion Date: | December 2009 |
| Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
I
Hypertonic resuscitation
|
|
2
Normal saline resuscitation
|
Eligibility| Ages Eligible for Study: | 15 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients enrolled in clinical trial of Hypertonic Resuscitation based on prehospital evidence of hypovolemic shock or severe brain injury
Inclusion Criteria:
- Blunt or Penetrating trauma with prehospital systolic blood pressure < 70 or 70-90 mmHg with Heart rate > 108 OR Blunt trauma with prehospital Glasgow coma score <= 8
Exclusion Criteria:
- Age < 15 yrs
- Known prisoners
- Pregnancy
- Ongoing CPR
- Burns < 20%
- Hypothermia < 28 C
- > 2 liters intravenous fluid prior to study fluid administration
- > 4 hour from time of dispatch
Contacts and Locations| United States, Washington | |
| University of Washington | |
| Seattle, Washington, United States, 98104 | |
| Canada | |
| University of Toronto | |
| Toronto, Canada | |
| Principal Investigator: | Eileen M Bulger, MD | University of Washington |
More Information
Additional Information:
No publications provided
| Responsible Party: | Eileen M. Bulger, MD, University of Washington |
| ClinicalTrials.gov Identifier: | NCT00750997 History of Changes |
| Other Study ID Numbers: | R01 GM076101-02 |
| Study First Received: | September 10, 2008 |
| Last Updated: | August 4, 2010 |
| Health Authority: | United States: Food and Drug Administration |
Additional relevant MeSH terms:
|
Inflammation Shock Shock, Hemorrhagic Brain Injuries Pathologic Processes Hemorrhage |
Brain Diseases Central Nervous System Diseases Nervous System Diseases Craniocerebral Trauma Trauma, Nervous System Wounds and Injuries |
ClinicalTrials.gov processed this record on May 22, 2013